DVA

DaVita Inc. DVA

$236.97 +2.96 (+1.26%)

Extended · +1.89σ

+ Compare Open in Sniper

Mkt cap $14.9B

P/E 22.1

Day $233.35 – $238.53

52wk $103.48 – $239.64

Avg vol —

Beta —

Div yld —

Next earnings —

Quick read

Plain English

DaVita Inc. is a healthcare company listed in the US.

DVA last traded at $236.97, up 1.3% on the day; that's in the upper part of its 52-week range ($103.48–$239.64). Right now it's trading above its recent average — momentum is positive, though some of the move may already be in the price.

Earnings reports are the biggest scheduled catalysts to keep an eye on, and after a strong run, watch whether the price can hold its gains on quieter days.

A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.

132-Day Trend Zones

Full chart →

21 EMA +1 ATR +2 ATR −2 ATR

—

O — H — L — C —

— —

Valuation & accounting

Valuation desk →

Our cash-flow model pegs fair value near $94.36 (fair range $94–$638); today's price sits 143% above that estimate. The model's verdict is “Overvalued” and accounting quality screens as Weak. Model estimates only — do your own due diligence.

Intrinsic (DCF)

$94.36

Fair-value range

$94.36 – $637.68

Margin of safety

-143%

Verdict

Overvalued

Accounting quality Weak

⚠ Debt exceeds cash
⚠ Quick ratio 0.98 (fragile)
⚠ Negative retained earnings
⚠ Receivables growing faster than revenue

Price implies ~13% growth (vs trailing rev yoy). Model estimate — do your own due diligence.

Key statistics

All statistics →

DVA is a $14.9 billion company, priced at 22× last year's earnings, and the stock is trading near the top of its 52-week range.

Mkt cap $14.9B

P/E ttm 22.1

Fwd P/E —

Beta —

Day range $233.35 – $238.53

52w range $103.48 – $239.64

Avg vol —

RSI(2) 87.3

ROE —

Net mgn —

FCF mgn 7.3%

Debt/Eq 12.61

Div yld —

Sector Healthcare

Industry Medical Care Facilities

Next earn —

52-week range · today's price

$103.48$239.64